Micellar nanoparticle technology has a broad range of application in pharmaceutical development. For example, we can expect various benefits by controlling drug release from micelles: improved safety by lowering drug concentration below the level where adverse effects may occur; increased stability of drug in the bloodstream whose half-life is very short; and higher therapeutic efficacy by increasing the amount of drugs delivered to the targeted lesions etc.